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The recent progress in our understanding of how
some proteins can recognize inositol lipids via spe-
cific binding domains, such as pleckstrin homology
(PH) domains, has been put to a good practical use
to measure these lipids in live cells in real time. But
what are the limitations, and what are the ways
forward?
One of the most remarkable burgeoning stories in cell
biology over the last 20 years has been that of the inos-
itol lipids and, even more so, the number of their func-
tions. All such functions are probably mediated by
effector proteins, and all of these must in turn be able
to recognize, by specific binding, the particular inositol
lipid in which they are interested. The best known inos-
itol-lipid-binding domains are some pleckstrin homol-
ogy (PH) domains, but there are others such as the
Fab1, YOTB, Vac1 and EEA1 (FYVE) domain and the
epsin amino-terminal homology (ENTH) domain adding
to the variety (see [1] for review).
There are seven polyphosphoinositol lipids to choose
from, and the emerging appreciation that we may be
able to find at least one protein domain that binds
specifically to each one of them leads to the exciting
possibility that we can use these domains as tools to
measure those lipids. The initial exploitation of these
domains built on the idea that by fusing a fluorescent
protein, such as green fluorescent protein (GFP), to an
inositol-lipid-specific binding domain, it should be pos-
sible to ‘see’ that lipid in living cells in real time. The first
realization of this dream came when Stauffer et al. [2]
put a GFP tag on the PH domain of phosphoinositide-
specific phospholipase C (PI-PLC) δ1, which specifically
binds phosphatidylinositol 4,5-bisphosphate
(PtdIns(4,5)P2), and showed that it lit up the plasma
membrane of transfected cells. When the cells were
stimulated with an agonist that activated PI-PLC, the
green ‘fringe’ of the cell dissolved into a cytoplasmic
haze – the PH domain had fallen off the plasma mem-
brane into the cytosol, telling us that, as expected,
PtdIns(4,5)P2 had been hydrolysed (Figure 1).
Another real-time imaging of inositol lipid metabolism
is illustrated by using PtdIns(3,4,5)P3-specific PH
domains. Here the translocation is the reverse – for
example, insulin stimulation of cells transfected with
such a GFP-tagged PH domain (of the ARF6 exchange
factor ARNO), causes a clear translocation of this
domain to the plasma membrane when PtdIns(3,4,5)P3
is generated there [3] (Figure 2). Similarly, the real-time
production and localisation of PtdIns3P has been fol-
lowed in Salmonella-transfected cells using a GFP-
tagged FYVE domain specific for that lipid [4]. Perhaps
even more exciting is the spatial aspect of inositol lipid
production that these probes can expose. For example,
during chemotaxis of macrophages or Dictyostelium
there is extensive polarisation of the enzymes that syn-
thesize and remove PtdIns(3,4,5)P3, and this has been
shown to be reflected by a gradient of the lipid itself –
revealed by a tagged PtdIns(3,4,5)P3-specific PH
domain [5].
However (and if there wasn’t a however, I wouldn’t
be writing this), over the last few years a few compli-
cations have arisen, and a new and complementary
approach to using these inositol lipid probes is begin-
ning to emerge. For example, the use of the PH
domain from PI-PLC δ1 to measure PtdIns(4,5)P2 is
markedly compromised by the fact that, as part of a
feedback-inhibition loop, the product of PtdIns(4,5)P2
hydrolysis, Ins(1,4,5)P3, competes very effectively with
PtdIns(4,5)P2 for the PH domain [6]. So, simply put, if
the PI-PLC δ1 PH domain falls off the plasma mem-
brane, we do not know if it is because PtdIns(4,5)P2
decreases or Ins(1,4,5)P3 increases, or both.
Hirose et al. [7] have used this competition by
Ins(1,4,5)P3 as an elegant single cell assay for
Ins(1,4,5)P3 production, and validated it by showing that
increasing Ins(1,4,5)P3-5-phosphatase levels by trans-
fection prevents the PH domain falling off the plasma
membrane. This finding essentially means that the
increase in Ins(1,4,5)P3 (and not the decrease in
PtdIns(4,5)P2) must be the major factor regulating the
localisation of the PH domain, at least in those cells.
This has led to some controversy regarding whether or
not this is true for all cells (for example, see [8]), but I
suspect that the most likely answer is that the localisa-
tion of this domain is usually regulated by a mechanism
that depends on the levels of both phosphoinositides
— that is, the more the PtdIns(4,5)P2 decreases, the
better the Ins(1,4,5)P3 can compete with it. Whatever
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Figure 1. Real-time visualisation of PtdIns(4,5)P2 hydrolysis. 
RBL cells have been transfected with the GFP-tagged PH
domain of PI-PLC δ1, which specifically binds to the
headgroup of PtdIns(4,5)P2, and thus it predominantly lights
up the plasma membrane (left, 0 sec). By 60 seconds after
platelet-activating factor has been applied to the cells, most
of the GFP-tagged protein has fallen off into the cytoplasm
(right), indicating that PtdIns(4,5)P2 hydrolysis has taken place
(see the text for a more detailed interpretation). Reproduced
from Figure 3 in [2].
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the answer, this issue does complicate any attempt to
quantify the actual levels of PtdIns(4,5)P2 in real time.
In addition, there is another problem with all these
experiments, and that is that the probe only reveals
what it can ‘see’. That the PH domain of PI-PLC δ1
lights up the plasma membrane almost exclusively in
most cells is itself puzzling, given that we know there is
plenty of PtdIns(4,5)P2 elsewhere, for example in the
Golgi, in endosomes and in the nucleus. It is in these
places that some of the ‘proliferation of functions’ of
PtdIns(4,5)P2 has occurred, and this reveals the ‘catch-
22’ of these probes: if PtdIns(4,5)P2 is functional, it must
be interacting with something, and this must be via its
headgroup (or it would not be specific); and if it is inter-
acting with that something, it cannot simultaneously
interact with the PH domain that is supposed to ‘see’ it.
So, unless there is a significant excess of PtdIns(4,5)P2
in a given location, PtdIns(4,5)P2 may not be visible to
the probe, and this may indeed be true in most parts of
the cell other than in the plasma membrane, where
there is usually plenty of ‘spare’ PtdIns(4,5)P2 for the PI-
PLCs and the PI 3-kinases to use as substrate. An
increase in ‘free’ PtdIns(4,5)P2 in intracellular compart-
ments has been detected using the PI-PLC δ1 PH
domain by Aikawa et al. [9], but this can only be semi-
quantitative, and perhaps it tells us no more than that
there are more PtdIns(4,5)P2 molecules inside the cell
with their headgroups exposed.
A recent and elegant way around these problems is
to use these probes on fixed tissue, just like an anti-
body. Antibodies to PtdIns(4,5)P2 and PtdIns(3,4)P2
are available, and these have been used to reveal, for
example, the localisation of these lipids in the nucleus
[10,11]. However, there are five other polyphospho-
inositol lipids, and we still know very little about
several of these, especially their distribution within the
cell. Thus the recent use of PH domains in electron
microscopy on fixed tissues by Jean Lucocq and Pete
Downes’ groups [12,13], is an especially enticing and
complementary approach. Their first sally used our old
friend the PH domain of PI-PLCδ1 [12], and the differ-
ence between these results and those obtained with
live cells as discussed above encapsulates the relative
strengths and weaknesses of the two approaches.
Carrying out electron microscopy on fixed tissues
requires a lot more work, and there is no real-time
readout. But you do, for the first time, get real quan-
tification of PtdIns(4,5)P2, and you get it in all parts of
the cell (and all in the same sample).
Watt et al. [13] have now extended this approach to
PtdIns(3,4)P2, an inositol lipid of considerable interest to
cell signallers, but about which we know very little (and
absolutely nothing about how much is where in the cell).
This group used the PH domain of TAPP1, which is very
specific in its interaction with PtdIns(3,4)P2. Indeed, the
structural details of this interaction [14], and the eluci-
dation of why TAPP binds only PtdIns(3,4)P2, and not
PtdIns(4,5)P2 nor PtdIns(3,4,5)P3, is an example of how
we can understand the way in which biology tinkers
with the sequence of a multi-functional domain to get
exquisite structural specificity. Watt et al. [13] have now
used this domain to show that, although PtdIns(3,4)P2 is
mostly in the plasma membrane, it is also found 
elsewhere in the cell, such as in multivesicular bodies
and the nucleus. Interestingly, the levels of PtdIns(3,4)P2
seem to be regulated differently in these locations —
treatment with platelet-derived growth factor (PDGF) or
hydrogen peroxide affects PtdIns(3,4)P2 levels in multi-
vesicular bodies but not in the nucleus.
Despite the caveats discussed above, there is still a
huge amount we can and will learn about these and
other inositol lipids by using these probes in living
cells, especially as more specific binding domains are
brought into play. However, the expansion of the use
of these probes into electron microscopy of fixed sec-
tions is clearly something that needs to take place in
parallel because of the respective merits of the two
approaches. There are exciting times ahead.
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Figure 2. Real-time visualisation of PtdIns(3,4,5)P3 production.
Adipocytes (3T3 L1 cells) have been transfected with the
GFP-tagged PH domain of ARNO, which specifically binds
the headgroup of PtdIns(3,4,5)P3. In unstimulated cells this
protein is mostly in the cytosol (control, left), but 60 seconds
after insulin is applied it translocates mostly to the plasma
membrane (right), indicating that synthesis of PtdIns(3,4,5)P3
has taken place. Reproduced from Figure 2 in [3].
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